Primary |
Eye Pruritus |
28.5% |
Eye Allergy |
11.0% |
Seasonal Allergy |
9.0% |
Hypersensitivity |
7.4% |
Dry Eye |
6.4% |
Off Label Use |
5.6% |
Vitamin Supplementation |
4.7% |
Ocular Hyperaemia |
4.6% |
Lacrimation Increased |
3.5% |
Hypertension |
2.9% |
Product Used For Unknown Indication |
2.9% |
Drug Use For Unknown Indication |
2.4% |
Multiple Allergies |
2.4% |
Eye Irritation |
2.0% |
Keratoconjunctivitis Sicca |
1.7% |
Blood Cholesterol Increased |
1.6% |
Urticaria |
0.9% |
Anxiety |
0.8% |
Cardiac Disorder |
0.8% |
Diabetes Mellitus |
0.8% |
|
Eye Irritation |
20.1% |
Instillation Site Pain |
19.0% |
Drug Ineffective |
16.1% |
Ocular Hyperaemia |
8.8% |
Eye Pain |
5.7% |
Instillation Site Irritation |
3.7% |
Vision Blurred |
3.4% |
Headache |
3.1% |
Eye Pruritus |
2.8% |
Drug Effect Decreased |
2.5% |
Lacrimation Increased |
2.5% |
Eyelid Oedema |
2.0% |
Drug Hypersensitivity |
1.4% |
Drug Ineffective For Unapproved Indication |
1.4% |
Mydriasis |
1.4% |
Rash |
1.4% |
Condition Aggravated |
1.1% |
Dry Eye |
1.1% |
Epistaxis |
1.1% |
Eye Swelling |
1.1% |
|
Secondary |
Eye Pruritus |
23.5% |
Off Label Use |
12.4% |
Lacrimation Increased |
10.5% |
Dry Eye |
10.2% |
Ocular Hyperaemia |
8.3% |
Eye Allergy |
7.0% |
Eye Irritation |
4.1% |
Hypersensitivity |
3.3% |
Keratoconjunctivitis Sicca |
3.1% |
Seasonal Allergy |
2.8% |
Anxiety |
1.7% |
Conjunctivitis Allergic |
1.7% |
Eyelid Margin Crusting |
1.7% |
Dermatitis |
1.5% |
Hypermetropia |
1.5% |
Product Used For Unknown Indication |
1.5% |
Eye Swelling |
1.3% |
Stent Placement |
1.3% |
Urticaria |
1.3% |
Hypertension |
1.1% |
|
Eye Irritation |
17.2% |
Instillation Site Pain |
15.9% |
Drug Ineffective |
13.4% |
Eye Pain |
8.9% |
Drug Ineffective For Unapproved Indication |
6.4% |
Ocular Hyperaemia |
5.7% |
Lacrimation Increased |
4.5% |
Vision Blurred |
3.8% |
Eye Pruritus |
3.2% |
Headache |
3.2% |
Drug Hypersensitivity |
2.5% |
Abdominal Distension |
1.9% |
Abnormal Sensation In Eye |
1.9% |
Bacterial Infection |
1.9% |
Eyelid Oedema |
1.9% |
Incorrect Dose Administered |
1.9% |
Mydriasis |
1.9% |
Condition Aggravated |
1.3% |
Epistaxis |
1.3% |
Eyelid Pain |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
18.0% |
Hypertension |
13.5% |
Hypersensitivity |
7.9% |
Anxiety |
4.5% |
Dry Eye |
4.5% |
Gastrooesophageal Reflux Disease |
4.5% |
Osteoporosis |
4.5% |
Back Pain |
3.4% |
Blood Calcium Decreased |
3.4% |
Blood Pressure Systolic Abnormal |
3.4% |
Diabetes Mellitus |
3.4% |
Dyspepsia |
3.4% |
Metastatic Renal Cell Carcinoma |
3.4% |
Musculoskeletal Pain |
3.4% |
Psoriatic Arthropathy |
3.4% |
Renal Cell Carcinoma |
3.4% |
Seasonal Allergy |
3.4% |
Supplementation Therapy |
3.4% |
Type 2 Diabetes Mellitus |
3.4% |
Cardiac Disorder |
2.2% |
|
Bronchitis Chronic |
6.3% |
Constipation |
6.3% |
Depression |
6.3% |
Inappropriate Schedule Of Drug Administration |
6.3% |
Increased Upper Airway Secretion |
6.3% |
Injection Site Pain |
6.3% |
Muscle Spasms |
6.3% |
Off Label Use |
6.3% |
Pharyngeal Neoplasm |
6.3% |
Pruritus |
6.3% |
Pyrexia |
6.3% |
Renal Failure |
6.3% |
Septic Shock |
6.3% |
Somnolence |
6.3% |
Vertigo |
6.3% |
Vision Blurred |
6.3% |
|